Research News and Research

RSS

RWJF selects Regions Hospital to take part in its effort to improve cardiac care delivered in hospitals

MN Community Measurement today announced that Regions Hospital has been selected by the Robert Wood Johnson Foundation (RWJF) to participate in a new effort to improve the quality -- and equality -- of cardiac care delivered in hospitals. The Aligning Forces for Quality: Equity Quality Improvement Collaborative (Equity QI Collaborative) will identify and test ways for hospitals to improve the quality and efficiency of their cardiac care, while also identifying and reducing any racial and ethnic disparities.

11 Sep 2009

First Edition: September 11, 2009

Today's headlines are full of second-day stories about the policies and politics involved in President Obama's Wednesday night address to Congress.

11 Sep 2009

USPTO recognizes RZN Nutraceuticals' HerbaZorb as a patentable delivery system

RZN Nutraceuticals, Inc.,(www.rznnutra.com) a leading developer of proven effective herbal products which have been clinically tested on sufferers of severe arthritis and migraines has announced receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for the firm's absorption and delivery system process methodology patent application, a technology RZN has named HerbaZorb(TM).

11 Sep 2009

Roche scientists use their xCELLigence System to analyze nutlin-induced apoptosis

The p53 tumor suppressor, a transcription factor that activates or inhibits hundreds of genes, either directly or indirectly, triggers a variety of cellular effects and plays a central role in the cellular defense against cancer. One of the main approaches for pharmacological intervention is to activate wild-type p53 in cancer cells by blocking MDM2 from binding to p53.

11 Sep 2009

BioOhio and GCIC launch Ohio Bioscience Resource Directory

BioOhio and the Global Cardiovascular Innovation Center (GCIC) have launched an expanded and improved Ohio Bioscience Resource Directory, the most comprehensive online collection of Ohio companies, organizations, and research centers involved in the biosciences.

11 Sep 2009

University of Pittsburgh invites media to participate in the eds-meds tour program

Media are invited to participate in the science and technology tours being held in conjunction with the Pittsburgh G-20 Summit Sept. 24-25. Twelve one-hour tours—hosted by the University of Pittsburgh, Carnegie Mellon University, and the University of Pittsburgh Medical Center—are being offered on Monday, Sept. 21. They will highlight the science and technology that is driving the region’s economy.

11 Sep 2009

Clarus Research Group announces results of survey on President Obama's speech to a Joint Session of Congress

Immediately after President Obama's speech to a Joint Session of Congress last night, Clarus Research Group surveyed 44 of the nation's top political, legislative and communications strategists -- representing a broad array of expertise in politics, government, media consulting, lobbying, and public relations.

11 Sep 2009

Solos obtains purchase order for surgical endoscopy instruments

Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has received a purchase order for the MammoView(TM) line of surgical endoscopy instruments from the University of Missouri Health System, which boasts one of the most comprehensive health-care networks in Missouri.

11 Sep 2009

Cymbalta maintains reduction in pain for patients with chronic low back pain

New data show patients with chronic low back pain on Cymbalta(R) (duloxetine HCl) maintained reductions in pain for 41 weeks. In patients who initially responded to duloxetine, this maintenance of pain reduction was accompanied by further reduction in pain that was statistically significant as measured by the Brief Pain Inventory (BPI) average pain rating.

11 Sep 2009

Phase 3 trial results of LEVADEX orally inhaled migraine therapy to be presented

MAP Pharmaceuticals, Inc. announced today that it will present analysis of data from the efficacy portion of the first Phase 3 trial of its novel LEVADEX orally inhaled migraine therapy, currently in development, at the 14th Congress of the International Headache Society.

11 Sep 2009

HCD Research to conduct a national study during President Barack Obama's speech on health care reform

HCD Research announced today that it will conduct a national study during President Barack Obama's speech on health care reform tonight to obtain Americans' perceptions of the president and his plan for health care reform.

11 Sep 2009

Majority of Americans want Congress to include lawsuit reform in the health care bill: Survey

A new nationwide poll reveals that a strong majority of America's voters want Congress to include lawsuit reform in any overhaul of the health care system.

11 Sep 2009

ERC funds DiaDrug project to study the link between insulin resistance and albuminuria

The European Research Council (ERC) expects to fund some 240 top researchers in its second prestigious ERC Starting Grant competition. This new wave of grantees follows the 299 researchers who received grants in the first Starting Grant competition in 2007. In total, 2503 proposals were submitted to the second Starting Grant call.

11 Sep 2009

Amylin and Biocon collaborate to develop a peptide therapeutic for treating diabetes

Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Biocon, Limited (NSE: BIOCON) announced today that they have entered into an exclusive agreement to jointly develop, commercialize and manufacture a novel peptide therapeutic for the potential treatment of diabetes. Amylin and Biocon will collaborate to develop the therapeutic potential of the compound and share development costs. Research will center on Amylin's "phybrid" technology.

11 Sep 2009

Scarab Genomics and Neoclone sign license agreement

Scarab Genomics, a leader in E coli technology, has entered into a license agreement with NeoClone to market and distribute their proprietary antibodies against Shiga toxin.

11 Sep 2009

Recession hits some biopharmaceutical companies and CROs

Recession-driven slowdowns in drug development mean problems for some biopharmaceutical companies and, by extension, the contract research organizations (CROs) they employ to test prospective therapies.

11 Sep 2009

Merck update on the status of telcagepant clinical development programs

Merck & Co., Inc. today updated the status of the clinical development programs for telcagepant (MK-0974) and MK-3207, the Company's investigational oral calcitonin gene-related peptide (CGRP) receptor antagonists for the intermittent treatment of acute migraine.

11 Sep 2009

President Barack Obama's speech on health care reform receives mixed reactions

A new national media study among 951 viewers of President Barack Obama's speech to Congress in which he focused on his plan for health care reform revealed that more than half of all political parties reported that the speech was "somewhat or extremely effective."

11 Sep 2009

Phase 3 trial of ataluren commences

PTC Therapeutics, Inc. (PTC) today announced the initiation of a Phase 3 trial of ataluren (formerly PTC124(R)), an investigational protein restoration therapy in patients with nonsense mutation cystic fibrosis (nmCF).

11 Sep 2009

H.R. 3200 health care reforms will benefit illegal aliens

"The reforms I'm proposing would not apply to those who are here illegally," President Obama said in a carefully worded statement to a Joint Session of Congress and the American public last night. The problem, notes the Federation for American Immigration Reform (FAIR), is that the health care reforms proposed in H.R. 3200, America's Affordable Health Care Act of 2009, clearly would benefit illegal aliens.

11 Sep 2009

Research News and Research

RWJF selects Regions Hospital to take part in its effort to improve cardiac care delivered in hospitals

First Edition: September 11, 2009

USPTO recognizes RZN Nutraceuticals' HerbaZorb as a patentable delivery system

Roche scientists use their xCELLigence System to analyze nutlin-induced apoptosis

BioOhio and GCIC launch Ohio Bioscience Resource Directory

University of Pittsburgh invites media to participate in the eds-meds tour program

Clarus Research Group announces results of survey on President Obama's speech to a Joint Session of Congress

Solos obtains purchase order for surgical endoscopy instruments

Cymbalta maintains reduction in pain for patients with chronic low back pain

Phase 3 trial results of LEVADEX orally inhaled migraine therapy to be presented

HCD Research to conduct a national study during President Barack Obama's speech on health care reform

Majority of Americans want Congress to include lawsuit reform in the health care bill: Survey

ERC funds DiaDrug project to study the link between insulin resistance and albuminuria

Amylin and Biocon collaborate to develop a peptide therapeutic for treating diabetes

Scarab Genomics and Neoclone sign license agreement

Recession hits some biopharmaceutical companies and CROs

Merck update on the status of telcagepant clinical development programs

President Barack Obama's speech on health care reform receives mixed reactions

Phase 3 trial of ataluren commences

H.R. 3200 health care reforms will benefit illegal aliens

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics